Hopfner Robert Lorne
Hopfner Robert Lorne, DIR, reported a transaction classified as exercise at Rallybio Corp involving 3562.000000 shares for an estimated $8477.56. Reported holdings after the transaction were 12758.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 12, 2026
- Filing date
- Oct 14, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RLYB price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-421747 Common Stock
- Transaction date
- Oct 12, 2026 Filed Oct 14, 2026, 08:34 PM · 2d delay
- Shares
- 3,562 sh $2.38 per share
- Estimated value
- $8.47k Computed from shares × price
- Holdings after
- 12,758 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025.
- F2
This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $51,500.
- F3
The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders.
- F4
The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 15, 2025 or the date of the Company's 2025 Annual Meeting of Stockholders.
0 other transactions
0 recent txs